Products Antibodies Polyclonal Antibodies Anti-NF-kB p65/RelA Rabbit Polyclonal Antibody for WB - Q04206
Anti-NF-kB p65/RelA Rabbit Polyclonal Antibody for WB - Q04206

Polyclonal Antibodies

Anti-NF-kB p65/RelA Rabbit Polyclonal Antibody for WB - Q04206

Item Number : CM0016668

Price varies based on specs and customizations


Application
WB, IP, IF/ICC, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
60 kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name NF-kB p65/RelA Rabbit pAb
Remarks/Alias p65; CMCU; NFKB3; AIF3BL3; NF-kB p65/RelA
Species Human
Gene ID (Human) 5970
Gene ID 5970
Immunogen Synthetic peptide corresponding to a sequence within amino acids 450-551 of human NF-kB p65/RelA (NP_068810.3)
Source Rabbit
Category Polyclonal Antibodies
Application WB, IP, IF/ICC, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS Q04206
Protein Weight 60 kDa
Shipping Ice bag

Biological Background: NF-kB p65/RelA Function and Localization

  • NF-kB p65/RelA, encoded by the RELA gene, is a subunit of the NF-kB transcription factor complex that exists as homo- or heterodimers; the heterodimeric p65-NFKB1 complex is the most abundant form.
  • It plays a central role in inflammation, immunity, cell growth, differentiation, and apoptosis by binding to kappa-B sites in target gene promoters, acting primarily as a transcriptional activator.
  • Among NF-kB family members (RELA, RELB, REL, NFKB1, NFKB2), p65/RelA is essential for cytokine gene expression in T-cells (PubMed:15790681). Related references: PMID:15790681
  • The subcellular localization of p65 is tightly regulated; in resting cells, it is sequestered in the cytoplasm by IκB inhibitors, and upon activation, it translocates to the nucleus.
  • p65/RelA is subject to multiple post-translational modifications including phosphorylation, acetylation, methylation, and ubiquitination, which modulate its transcriptional activity and stability.
  • It is also involved in host-virus interactions, acting as a key transcription factor regulating the interferon response during SARS-CoV-2 infection (PubMed:33440148). Related references: PMID:33440148
  • The protein has a predicted molecular weight of approximately 60 kDa (UniProt: 60219 Da) and is expressed in nearly all cell types.

Experimental Guidance and Technical Tips

  • The immunogen corresponds to the C-terminal transactivation domain (aa 450-551) of human p65/RelA; antibody reactivity may be influenced by post-translational modifications in this region.
  • For Western blotting, a band around 60 kDa is expected; consider including appropriate positive and negative controls (e.g., stimulated vs. unstimulated cells) to confirm specificity.
  • In immunoprecipitation, the polyclonal nature may provide robust capture; validate in the relevant sample system to confirm efficient pulldown of the p65 complex.
  • For immunofluorescence/ICC, anticipate nuclear translocation upon NF-κB pathway activation; use fixation and permeabilization conditions suitable for nuclear antigens.
  • This antibody is recommended for ELISA; verify optimal coating and detection conditions with recombinant p65 or cell lysates.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides diagnostic manufacturers and laboratories with integrated access to high-quality IVD raw materials, including validated antibody pairs and bulk ancillary reagents. For NF-κB signaling and inflammation research, CamelBio offers customized sourcing solutions for polyclonal antibodies like this anti-p65/RelA, along with technical consulting from concept to clinic. Explore our one-stop platform to streamline your raw material procurement.

View more faqs for this product

Product Datasheet

Anti-NF-kB p65/RelA Rabbit Polyclonal Antibody for WB - Q04206


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!